GovChime

6505-01-624-7068 Omeprazole extended-release caps

One item DLA buys: its open requests for quotation, approved sources and past DLA awards.

Overview

National Stock Number record

Open RFQs
1
Next due November 18, 2026
Last price paid
…
Standard price
$96.47 per BT
DLA's catalog price, not a price paid
Approved sources
2
Awards on record
572
2016 to 2026
DLA demand
–

Identification

Item name
Omeprazole extended-release caps
NSG (group)
65 · Medical/dental/veterinary eqpt/supp
NIIN assigned
13-JAN-14
Unit
BT
NSN
6505-01-624-7068
NIIN
01-624-7068

Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

Approved suppliers

Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record

SupplierCAGECAGE statusPart status (RNCC / RNVC)Supplier part #Listed in
SANDOZ INC.0THL4A (Active)3 (Design control reference) / 2 (An item-identifying number)NDC00781-2868-92DLA approved-source file
1HT23NDC 51407081390DLA approved-source file
64616A (Active)5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information)6505NCM139694FLIS part list
89875A (Active)5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information)1166738FLIS part list

Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.

Pricing and awardees

Supply contracts

4 contracts DLA ordered this item under

Award IDAwardeeAwarding officeCeilingOrdering endsTypeMultiple awardOrdersLast order
SPE2DX25D8022CARDINAL HEALTH, INC.SPE2DX$76,117,432March 6, 2035INDEFINITE DELIVERY / REQUIREMENTSNo57October 16, 2026
SPE2DX25D9900DMS PHARMACEUTICAL GROUP INCSPE2DX$19,999,999March 6, 2038INDEFINITE DELIVERY / REQUIREMENTSNo8July 13, 2026
SPE2DX25D9822DMS PHARMACEUTICAL GROUP INCSPE2DX$20,000,000March 6, 2035INDEFINITE DELIVERY / REQUIREMENTSNo2February 17, 2026
SPE2DX15D9383DMS PHARMACEUTICAL GROUP INCSPE2DX$4,999,999December 31, 2025INDEFINITE DELIVERY / INDEFINITE QUANTITYNo20December 18, 2018

Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.

Characteristics

Government-defined characteristics of this item (FLIS)

Hazardous and environmental

Hazardous material (HMIC)
P (No information in hmirs)

Product characteristics

CodeRequirementDescription
CSGSAdministrationORAL
AKJFLong action methodDELAYED RELEASE
CXCYPart name assigned by controlling agencyOMEPRAZOLE 20MG DELAYED RELEASE CAPSULE BT 90S
AJCNProtective storage featureCONTROLLED ROOM TEMPERATURE
FEATSpecial features20 MG ACTIVE INGREDIENT; DELAYED-RELEASE CAPSULE; BOTTLE OF 90; MFG. BY MYLAN PHARM FOR GOLDEN STATE MEDICAL; STORE AT CONTROLLED ROOM TEMP

Additional identifiers

II
0
DEMIL
A: No demilitarization required
Precious metals (PMIC)
A (Does not contain precious metal)
Schedule B
3004909260 (Medicaments primarily affect digest system nesoi)
PINC
0042777
Criticality (CRIT CD)
X
On FedMall
Yes

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

Major organizational entity (MOE) rules

How each service or agency buys and manages this item

RuleMOEAMCAMSCNIMSCIMCAACDSOR
A911Army (DA)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
FSGMAir Force (DF)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
MC55Marine Corps (DM)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item
N9BLNavy (DN)3From the actual manufacturer (second or later time)ZCommercial or off-the-shelf item

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.

Government organizations

The services and agencies that manage or use this item

OrganizationEffective dateUnit of issueUnit priceQty per unitControlled inventoryShelf lifeAcquisition adviceSource of supply
Army (DA)01-OCT-2025BT$70.181 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Air Force (DF)01-OCT-2025BT$70.181 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Marine Corps (DM)01-OCT-2025BT$70.181 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
Navy (DN)01-OCT-2025BT$70.181 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)
DLA (DS)01-OCT-2026BT$96.471 (1)U (Unclassified)M (24 months)L (Local purchase)SMS (Defense logistics agency)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.

Packaging

FLIS packaging data of this item

FLIS packaging

Level A
Z (Special requirement)
Level B
Z (Special requirement)
Unit container
ZZ (Special requirement)

Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).

DIBBS RFQs

Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now

SolicitationNSNItem nameQtyUnitStd. priceLast priceEst. valueSet-asideTech docsPostedReturn by
SPE2DP27T0313DIBBS only6505-01-624-7068Omeprazole extended-release caps23BT$96.47 per BT……No set-asideNoNovember 12, 2026November 18, 20264 days left
SPE2DP27T0190DIBBS only6505-01-624-7068Omeprazole extended-release caps54BT$96.47 per BT……No set-asideNoOctober 27, 2026November 2, 2026Closed
SPE2DP27T0177DIBBS only6505-01-624-7068Omeprazole extended-release caps6BT$96.47 per BT……No set-asideNoOctober 25, 2026November 2, 2026Closed
SPE2DP26T4887DIBBS only6505-01-624-7068Omeprazole extended-release caps1BT$96.47 per BT……No set-asideNovember 3, 2026First seenSeptember 8, 2026Closed
SPE2DP26T5014DIBBS only6505-01-624-7068Omeprazole extended-release caps2BT$96.47 per BT……No set-asideNovember 3, 2026First seenSeptember 16, 2026Closed
SPE2DP26T5226DIBBS only6505-01-624-7068Omeprazole extended-release caps6BT$96.47 per BT……No set-asideNovember 3, 2026First seenSeptember 30, 2026Closed

→ These RFQs in the DIBBS list

“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.

DLA forecast

DLA's purchase forecast for the next 24 months, and its lead time

DLA's own figures

Lead time
administrative 15 days, production 113 days (128 in all)

Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).

DLA award history

572 award lines since 2016, 5 winning CAGEs

WinnerAwardsLast award
1UNB0DMS PHARMACEUTICAL GROUP INC406July 13, 2026
00E55Cardinal Health, Inc.59November 10, 2026
3W8H0MR UNLIMITED, LLC53October 13, 2026
49KA0ASE DIRECT, INC.53December 18, 2023
0ZSM5NAR MEDICAL DEPOT, LLC1August 2, 2016
YearAwardsWinning CAGEs
2026703
20251371
2024702
2023512
2022343
2021511
2020511
2019261
2018201
2017131

Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.

DLA awards for this item

25 awards from the item's award history, in FPDS

RankVendorObligated
1DMS PHARMACEUTICAL GROUP INC$37,084
2MR UNLIMITED, LLC$3,737
3ASE DIRECT, INC.$2,161
4CARDINAL HEALTH, INC.$704
ContractAwardedAwardeeObligated
SPE2D926F8263From the item's award historyAugust 14, 2026CARDINAL HEALTH, INC.$7
SPE2D926F8208From the item's award historyAugust 13, 2026CARDINAL HEALTH, INC.$13
SPE2D926F8214From the item's award historyAugust 13, 2026CARDINAL HEALTH, INC.$20
SPE2D926F8222From the item's award historyAugust 13, 2026CARDINAL HEALTH, INC.$7
SPE2D926F8159From the item's award historyAugust 10, 2026CARDINAL HEALTH, INC.$145
SPE2D926F8164From the item's award historyAugust 10, 2026CARDINAL HEALTH, INC.$7
SPE2D926F8025From the item's award historyAugust 7, 2026CARDINAL HEALTH, INC.$53
SPE2D926F7977From the item's award historyAugust 6, 2026CARDINAL HEALTH, INC.$33
SPE2D926F7955From the item's award historyAugust 5, 2026CARDINAL HEALTH, INC.$33
SPE2D926F7867From the item's award historyAugust 3, 2026CARDINAL HEALTH, INC.$7

Showing 1 to 10 of 25 results

Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.

Winning bids